Publications
Print PDF
FDA Under Temporary New Leadership as Senate Considers Nominee
November 5, 2019
Mari Serebrov
BioWorld

Axinn partner Chad Landmon was quoted in the BioWorld article, "FDA Under Temporary New Leadership as Senate Considers Nominee."

Click here to access the article. A subscription is required.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.